Characteristic no rSO2 desaturation, N = 581 rSO2 desaturation (>20% from baseline), N = 321 p-value2
Patient Age 81 (7) 79 (5) 0.15
Patient Sex

0.006
    0 39 / 58 (67%) 12 / 32 (38%)
    1 19 / 58 (33%) 20 / 32 (63%)
Acute Kidney Injury 8 / 58 (14%) 11 / 32 (34%) 0.022
Body Mass Index 27.6 (5.5) 27.3 (5.8) 0.83
Length of Hospital Stay 10.4 (4.6) 13.1 (5.6) 0.026
Diabetes Type II (Insulin-dependent)

0.018
    0 49 / 58 (84%) 20 / 32 (63%)
    1 9 / 58 (16%) 12 / 32 (38%)
Hyperlipoproteinemia

0.27
    0 33 / 58 (57%) 22 / 32 (69%)
    1 25 / 58 (43%) 10 / 32 (31%)
Smoker

0.34
    0 44 / 51 (86%) 24 / 31 (77%)
    1 6 / 51 (12%) 4 / 31 (13%)
    2 1 / 51 (2.0%) 3 / 31 (9.7%)
    Unknown 7 1
Chronic Obstructive Pulmonary Disease

>0.99
    0 51 / 58 (88%) 29 / 32 (91%)
    1 7 / 58 (12%) 3 / 32 (9.4%)
Arterial Hypertension

0.56
    0 12 / 58 (21%) 5 / 32 (16%)
    1 46 / 58 (79%) 27 / 32 (84%)
Coronary Heart Disease

>0.99
    0 20 / 58 (34%) 11 / 32 (34%)
    1 38 / 58 (66%) 21 / 32 (66%)
Coronary Artery Bypass Graft

>0.99
    0 53 / 58 (91%) 30 / 32 (94%)
    1 5 / 58 (8.6%) 2 / 32 (6.3%)
Percutaneous Coronary Intervention (PTCA)

0.77
    0 38 / 58 (66%) 20 / 32 (63%)
    1 20 / 58 (34%) 12 / 32 (38%)
Atrial Fibrillation

0.88
    0 39 / 58 (67%) 21 / 32 (66%)
    1 19 / 58 (33%) 11 / 32 (34%)
Hypertensive Heart Disease

0.16
    0 54 / 58 (93%) 26 / 32 (81%)
    1 4 / 58 (6.9%) 6 / 32 (19%)
Peripheral Arterial Occlusive Disease (PAOD)

0.72
    0 53 / 58 (91%) 28 / 32 (88%)
    1 5 / 58 (8.6%) 4 / 32 (13%)
Previous Myocardial Infarction

0.72
    0 53 / 58 (91%) 28 / 32 (88%)
    1 5 / 58 (8.6%) 4 / 32 (13%)
Previous Stroke

0.61
    0 56 / 58 (97%) 30 / 32 (94%)
    1 2 / 58 (3.4%) 2 / 32 (6.3%)
NYHA Stadium

0.92
    2 10 / 55 (18%) 4 / 28 (14%)
    3 41 / 55 (75%) 22 / 28 (79%)
    4 4 / 55 (7.3%) 2 / 28 (7.1%)
    Unknown 3 4
1 Mean (SD); n / N (%)
2 Welch Two Sample t-test; Pearson’s Chi-squared test; Fisher’s exact test